Skip to main content

Vanguard Capital Wealth Advisors

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 1730578 DENVER, CO

Position in NAUT

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$24,310
-$26,130 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#70
of 93 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NAUT Over Time

Shares Held

Position Value (USD)

Derivatives in NAUT

reported options exposure · as of Jun 30, 2023
CallValue
$938
CallShares
2,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vanguard Capital Wealth Advisors holds $1,003,641 across 3 Biotechnology names. NAUT ranks #3 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NAUT
Nautilus Biotechnology, Inc.
This page
13,000 $24,310

All Filings in NAUT

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,310 13,000
2026-03-31 $50,440 13,000
2025-12-31 $25,350 13,000
2025-09-30 $11,407 13,500
2025-06-30 $11,600 16,000
2025-03-31 $13,776 16,000
2024-12-31 $52,920 31,500
2024-09-30 $99,750 35,000
2024-06-30 $81,900 35,000
2024-03-31 $107,310 36,500
2023-12-31 $119,600 40,000
2023-09-30 $145,360 46,000
2023-06-30 $228,330 59,000
2023-06-30 $938 2,500
2023-03-31 $209,135 75,500
2022-12-31 $41,400 23,000
2022-09-30 $47,700 22,500
2022-06-30 $65,098 24,200
2022-03-31 $115,878 26,700
2021-12-31 $235,690 45,500